Delivery Order SPE2DB24D2217-SPE2DB25FJXTL
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,180.96 delivery order for 100 tablets of Clobazam 10 mg, with an ultimate completion date of August 1, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for military and veteran healthcare systems. The award...
- The Defense Logistics Agency awarded a $3,191.96 delivery order to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100s) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed price contract represents a non-competitive set-aside delivery order, with performance based in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Clobazam 10 mg tablets (100-count) with a ceiling value of $3,414.22. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Clobazam 10 mg tablets (100-count) valued at $2,214.14. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and requires completion by September 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a leading pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,622.52 on August 14, 2025, for the supply of Clobazam 10 mg tablets (100 count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 15, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Clobazam 10 mg tablets (100 count) with a ceiling value of $4,491.92. This is a firm fixed price delivery order with no set-aside designation, executed under competitive procedures. The order is scheduled for ultimate completion on August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100 units, with a ceiling value of $6,419.43 and an ultimate completion date of September 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The place of performance is AmerisourceBergen's corporate office located in Conshohocken,...
- The Defense Logistics Agency has awarded a delivery order valued at $2,200.40 to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price contract with no set-aside designation was executed on August 5, 2025, and carries an ultimate completion date of August 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its...
- The Defense Logistics Agency awarded a $5,030.27 firm fixed price delivery order to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-set-aside contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $3,194.98 delivery order to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets (100 count) under a firm fixed-price contract type. The award, made on September 4, 2025, with an ultimate completion date of September 5, 2025, is not designated as a set-aside contract and represents a competitively awarded transaction. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB24D2217Indefinite Delivery Contract
- SPE2DB24D2217-SPE2DB25FJXTLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100 units, with a ceiling value of $3,111.86. This is a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The ultimate completion date is September 15, 2025. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies globally to support military healthcare programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical procurement support to federal agencies, particularly the Defense Logistics Agency and military healthcare systems. The company's contract portfolio demonstrates substantial capability in delivering diverse pharmaceutical products across multiple therapeutic domains, with past awards ranging from small transactions under $100 to orders exceeding $45,000. This delivery order for Clobazam, an anti-seizure medication, exemplifies the company's role in supplying specialized pharmaceutical commodities to support defense and veteran healthcare needs through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 9/12/25 |